Oxford Immunotec Global PLC Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015
Revenue:
Product
Service
Total revenue
Product
Service
Total revenue
Cost of revenue:
Product
Service
Total cost of revenue
Cost of goods and services sold
Product
Service
Total cost of goods and services sold
Gross profit
Operating expenses:
Research and development
Sales and marketing
General and administrative
Change in fair value of contingent purchase price consideration
Intangible assets impairment charges
Settlement expense
Total operating expenses
Operating loss from continuing operations
Other income (expense):
Interest income (expense), net
Loss on extinguishment of debt
Foreign exchange gains (losses)
Other income (expense)
Litigation settlement income
Loss from continuing operations before income taxes
Income tax benefit from continuing operations
Income (loss) from continuing operations
Discontinued operations:
Income (loss) from discontinued operations before income taxes
Gain on disposition
Income tax expense
Income (loss) from discontinued operations
Net income (loss)
Net loss per ordinary share—basic and diluted (in dollars per share)
Weighted-average shares used to compute net loss per ordinary share—basic and diluted (in shares)
Net income (loss) per ordinary share—basic:
Income (loss) from continuing operations (in dollars per share)
Income (loss) from discontinued operations (in dollars per share)
Net income (loss) (in dollars per share)
Net income (loss) per ordinary share—diluted:
Income (loss) from continuing operations (in dollars per share)
Income (loss) from discontinued operations (in dollars per share)
Net income (loss) (in dollars per share)
Basic (in shares)
Diluted (in shares)

Comments